Impact Biomedical (IBO) Assets Average (2023 - 2026)

Impact Biomedical (IBO) has reported Assets Average for 4 consecutive years, with $16.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 13.5% year-over-year to $16.9 million; the trailing twelve-month figure through Jun 2026 stood at $16.9 million (down 13.5% YoY), and the FY2025 full-year result was $18.8 million, down 41.94% from the prior year.
• Assets Average fell to $16.9 million in Q2 2026 per IBO's latest filing, from $17.2 million in the prior quarter.
• Across five years, Assets Average topped out at $45.5 million in Q3 2023 and bottomed at $16.9 million in Q2 2026.
• Historically, Assets Average has averaged $30.7 million across 4 years, with a median of $26.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Assets Average retreated 0.29% in 2024, then plunged 58.96% in 2025.
• Over 4 years, Assets Average stood at $44.9 million in 2023, then dropped by 25.34% to $33.5 million in 2024, then slumped by 46.83% to $17.8 million in 2025, then declined by 5.0% to $16.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $16.9 million, $17.2 million, and $17.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.